At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LGVN Longeveron Inc
Pre-Market Trading 11-21 08:48:08 EST
1.85
+0.00
0.00%
盘前1.84
-0.01-0.41%
08:36 EST
High1.90
Low1.78
Vol299.32K
Open1.84
D1 Closing1.85
Amplitude6.41%
Mkt Cap26.57M
Tradable Cap20.69M
Total Shares14.36M
T/O556.54K
T/O Rate2.68%
Tradable Shares11.19M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
We're Keeping An Eye On Longeveron's (NASDAQ:LGVN) Cash Burn Rate
Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (Ctad24)
Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)
Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting
BRIEF-Longeveron® Lomecel-B™ Data In Alzheimer’S Disease Selected For Late Breaking Poster Presentation At The Clinical Trials On Alzheimer’S Disease Conference
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, a candidate in Phase 2a/b trials that is used for the treatment of alzheimer's disease, hypoplastic left heart syndrome, and aging-related frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.